79 results
10-K
2021 FY
EX-31.1
APGN
Apexigen Inc
7 Apr 22
Annual report
5:13pm
, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability
10-K
2021 FY
EX-31.2
APGN
Apexigen Inc
7 Apr 22
Annual report
5:13pm
, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability
8-K
EX-99.1
b90 da2iq4dxvri8w0j
2 Feb 21
Brookline Capital Acquisition Corp. Announces Pricing of $50,000,000 Initial Public Offering
5:21pm
8-K
EX-99.2
mwd 9oewlaomqey4l
2 Feb 21
Brookline Capital Acquisition Corp. Announces Pricing of $50,000,000 Initial Public Offering
5:21pm
8-K
2e6ea8wzn
12 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:25pm
425
zfwvcuz2ha9z9s528osk
11 Jul 22
Business combination disclosure
5:24pm
425
lwwxpzi
22 Apr 22
Business combination disclosure
4:41pm
8-K
EX-99.1
ql91n
27 Jul 22
Brookline Capital Acquisition Corp. and Apexigen, Inc. Announce Stockholder Approval of
5:41pm
425
so9zx005
9 May 22
Business combination disclosure
5:07pm
8-K
EX-99.1
k5ni4r008xv40y
14 Nov 22
Changes in Registrant's Certifying Accountant
4:07pm
425
wt2rl5j1vkr8 e8j
8 Jun 22
Business combination disclosure
5:25pm
8-K
EX-99.1
up7hnoo
26 Apr 22
Amendments to Articles of Incorporation or Bylaws
5:02pm
425
vb7bg
29 Jun 22
Business combination disclosure
4:39pm
8-K
EX-99.1
jtc zw1seso
18 Jul 22
Apexigen and Brookline Capital Acquisition Corp. Announce Effectiveness of Registration Statement
5:11pm
425
j78tdy33m2wtq5gzfqb
3 Jun 22
Business combination disclosure
4:57pm